Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 19 May 2000: Vol. 288. no. 5469, p. 1135 DOI: 10.1126/science.288.5469.1135a
|
|
Technical Comments
Diversity of Human  T Cell Receptors
Arstila et al. (1) estimated an
average diversity of 9 × 105 different chains and 4.5 × 105 different chains in the human naïve T
cell repertoire. To calculate the total T cell repertoire diversity,
the -chain diversity was estimated within a certain variable (V)
gene family, V 12+, comprising 2.5% of the
total -chain repertoire. Finding in this particular family an
estimated total of 6 × 105 different chains (i.e.,
two-thirds of the total -chain repertoire), Arstila et
al. suggested that the total T cell receptor (TCR) diversity
comprises at least (6 × 105) × 40 = 2.4 × 107 different  combinations (1). The
authors acknowledge that this is only a lower bound, because the
calculation assumes that the chains that do bind at least one
V 12 chain bind only one of the 4.5 × 105 different chains in the
V 12+ family. If each chain found
within the V 12+ family were to bind an
average of n different V 12 chains instead, the total estimated TCR diversity would be n-fold
higher than this lower bound.
Arstila et al. estimated an upper bound of 108
different  combinations (1). Pre-T cells having
rearranged a chain expand 1000-fold before the chain is
rearranged, and only 10% of these cells leave the thymus to enter the
mature repertoire. Thus, it was argued that each chain can
maximally pair with any of about 100 different chains.
This is indeed correct for all descendants of any particular pre-T
cell having rearranged a particular chain--but another pre-T cell
rearranging the same chain may bind to 100 different chains.
Thus, to calculate the upper bound on TCR diversity, one has to
consider the frequency with which identical -chain rearrangements
are expected. This frequency can be estimated from the turnover rate of
the naïve T cell repertoire. In human adults, the total body
production of naïve T cells has been estimated at about
108 per day (2), a figure obtained from recovery
rates following T cell depletion (2) and from an estimated 0.1% turnover (3) in a pool of 1011
naïve T lymphocytes. Assuming that most of this production is of thymic origin (4) and that more than 90% of the
cells die before leaving the thymus (1), this implies a
daily production of at least 109 pre-T cells. The
1000-fold expansion of the pre-T cells (1) before -chain
rearrangement implies that approximately 106 chains
should be made every day. Because this is close to the Arstila et
al. estimate of total -chain diversity, every chain should
be rearranged about every day.
Over the 1000-day expected life-span (2, 3) of
the progeny of a pre-T cell expressing a single chain, therefore,
1000 recurrences of the same -chain rearrangement might be
expected. Hence, the upper bound for the total TCR diversity could
easily be 1000-fold larger than calculated by Arstila et al.
Such an upper bound, at 1011, would allow almost every T
cell in the naïve repertoire to have a unique TCR. The true TCR
diversity may be several fold lower, however, owing to factors such as
proliferation after the -chain rearrangement and possible
restrictions in  -chain pairing.
Can Ke mir
José A.M. Borghans
Rob J. de Boer
Department of Theoretical Biology Utrecht University Padualaan 8 3584 CH Utrecht, The Netherlands E-mail: R.J.deBoer{at}bio.uu.nl
REFERENCES
-
T. P. Arstila,
et al.,
Science
286,
958
(1999)
[Abstract/Free Full Text]
.
-
D. R. Clark,
R. J. De Boer,
K. C. Wolthers,
F. Miedema,
Adv. Immunol.
73,
301
(1999)
[Web of Science] [Medline]
.
-
C. A. Michie,
A. McLean,
C. Alcock,
P. C. Beverley,
Nature
360,
264
(1992)
[CrossRef] [Medline]
.
-
B. F. Haynes,
et al.,
J. Clin. Invest.
103,
453
(1999)
[Web of Science] [Medline]
.
17 February 2000; accepted 4 April 2000
Response: Ke mir et al. argue
that although any developing TCR chain will be paired at most with
100 different chains, the same chain may appear repeatedly and
garner other sets of 100 chains, increasing the total  TCR
diversity from the 108 we estimated (1). We
studied the diversity of the human  TCR in the blood of healthy
adult donors at a given moment, not over time. Also, we did not measure
the upper limit of -to- pairing; our estimate was based on what
is known of  T cell development and TCR rearrangement. Thus, the
comment of Ke mir et al. actually goes beyond our
data.
Because any expansion after -chain rearrangement will increase only
clone size, not diversity, the argument of Ke mir et al. hinges on the assumption that the estimated total turnover of
naïve T cells equals thymic production of pre-T cells. That assumption is incorrect, however, and ignores the well-documented role
of post-developmental division in the maintenance of the naïve
T cell population, especially in adults. Murine T cells may go through
up to six cell cycles after -chain rearrangement even before
emigrating from the thymus (2). Haynes et al.,
cited by Ke mir et al., specifically argued for
"minimal contributions of the thymus to maintenance or reconstitution
of the peripheral pool of T cells . . ." in humans [(3), p. 457], and showed that the presence or absence of thymic function and even the surgical removal of the thymus had no impact on the reconstitution of the T cell compartment, including the naïve CD4+ cells, in treated HIV-infected individuals.
Naïve T cells, long after having completed TCR rearrangement,
clearly have a considerable capacity for self-renewal.
The suggestion of Ke mir et al. can also be viewed as
a question of clone size. If the size of the repertoire is
108 different TCRs, as we suggest, the average clone among
1011 naïve T cells would consist of 1000 cells, the
progeny of a single intrathymic -chain rearrangement after 10 cell
cycles. These cycles should therefore be detectable in the
naïve T cell population, and indeed this appears to be the
case. Studying the disappearance of cells damaged by therapeutic
irradiation, McLean and Michie (4) concluded that,
on average, naïve T cells divide once every 3.5 years and die
after 20 years, which suggests six post-thymic cell cycles in the
life-span of an average naïve T cell. Other experimental
approaches have suggested higher division rates. From age 25 to 70 years the mean telomere length in the naïve T cell population
decreases from 9.5 kb to 8.0 kb, so an estimated loss of 50 to 100 base
pairs (bp) per cell cycle translates to 7 to 13 divisions during the
20-year life-span of naïve cells (5). De Boer and
Noest have argued that this estimate of telomere loss is too high;
their estimate, 35 to 70 bp per cycle (6), would
mean 10 to 19 cycles. At any given time the fraction of naïve T
cells in cell cycle is 0.8% (7), which suggests a
rate as high as one division per 125 days, or 60 cycles per life-span.
The available data thus can easily accommodate 10 divisions producing
the average naïve clone.
Studies on the frequency of antigen-specific T cell precursors
provide an independent line of evidence that points to a diversity close to what we proposed. A conservative estimate of the frequency of
such precursors in the naïve repertoire would be one per
million; some studies have reported significantly higher frequencies
(8, 9). Thus, a total repertoire of 108 TCRs
would predict an epitope-specific response to consist of 100 clones,
while Ke mir et al.'s repertoire of
1011 TCRs predicts a composition of 100,000 responding
clones. The existing literature is more compatible with our prediction
(10-14). Thus, we submit that the phenomenon that
Ke mir et al. postulate, although in principle
possible, has little impact on the total diversity.
T. Petteri Arstila
Department of Virology Haartman Institute University of
Helsinki 00014 Helsinki, Finland E-mail:
petteri.arstila{at}helsinki.fi
Armanda Casrouge
Véronique Baron
Jos Even
Jean Kanellopoulos
Philippe Kourilsky
Unité de Biologie Moléculaire du Gène INSERM U277 Institut Pasteur Paris Cedex 15, France
REFERENCES
-
T. P. Arstila et al., Science
286, 958 (1999).
-
K. J. Hare,
R. W. Wilkinson,
E. J. Jenkinson,
G. Anderson,
J. Immunol.
160,
3666
(1998)
[Abstract/Free Full Text]
.
-
B. F. Haynes et al., J. Clin.
Invest. 103, 453 (1999).
-
A. R. McLean and
C. A. Michie,
Proc. Natl. Acad. Sci. U.S.A.
92,
3707
(1995)
[Abstract/Free Full Text]
.
-
N. P. Weng,
B. L. Levine,
C. H. June,
R.
J. Hodes,
Proc. Natl. Acad. Sci. U.S.A.
92,
11091
(1995)
[Abstract/Free Full Text]
.
-
R. J. De Boer and
A. J. Noest,
J. Immunol.
160,
5832
(1998)
[Abstract/Free Full Text]
.
-
N. Sachsenberg et al., J. Exp. Med.
187, 1295 (1998).
-
A. Hoffenbach et al., J. Immunol.
142, 452 (1989).
-
M. Lucchiari et al., Int. Immunol.
6, 1739 (1994).
-
S. A. Kalams et al., J. Exp. Med.
179, 1261 (1994).
-
M. F. C. Callan et al., Nat.
Med. 2, 906 (1996).
-
Y. N. Naumov,
K. T. Hogan,
E. N. Naumova,
J. T. Pagel,
J. Gorski,
J. Immunol.
160,
2842
(1998)
[Abstract/Free Full Text]
.
-
P. Bousso and
P. Kourilsky,
Semin. Immunol.
11,
423
(1999)
[CrossRef] [Web of Science] [Medline]
.
-
M. P. Weekes,
M. R. Wills,
K. Mynard,
A. J. Carmichael,
J. G. P. Sissons,
J. Virol.
73,
2099
(1999)
[Abstract/Free Full Text]
.
15 March 2000; accepted 4 April 2000
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.
- C. Lonchay, P. van der Bruggen, T. Connerotte, T. Hanagiri, P. Coulie, D. Colau, S. Lucas, A. Van Pel, K. Thielemans, N. van Baren, et al. (2004)
PNAS
101, 14631-14638
| Abstract »
| Full Text »
| PDF »
|
|